• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

4-(Piperidin-2-yl)butanoic acid hydrochloride: A Comprehensive Overview

4-(Piperidin-2-yl)butanoic acid hydrochloride (CAS No. 63987-69-9) is a chemical compound that has garnered significant attention in the fields of pharmaceutical research and organic synthesis. This compound, often referred to as 4-(piperidin-2-yl)butanoic acid HCl, is characterized by its unique structure, which combines a piperidine ring with a butanoic acid moiety. The compound has been extensively studied for its potential applications in drug development, particularly in the design of bioactive molecules and as an intermediate in the synthesis of complex organic compounds.

The molecular structure of 4-(piperidin-2-yl)butanoic acid hydrochloride is defined by a six-membered piperidine ring, which is a saturated heterocyclic structure containing one nitrogen atom. The piperidine ring is attached to a butanoic acid group via a methylene bridge, resulting in a flexible and versatile molecule. This structural arrangement allows for a wide range of chemical reactivity and biological activity, making it an attractive target for researchers in the pharmaceutical industry.

Recent studies have highlighted the potential of 4-(piperidin-2-yl)butanoic acid hydrochloride as a precursor for the synthesis of bioactive compounds with therapeutic applications. For instance, researchers have explored its use in the development of neuroprotective agents and anti-inflammatory drugs. The compound's ability to modulate cellular signaling pathways and interact with key biological targets has been extensively investigated, with promising results reported in preclinical models.

In terms of synthesis, 4-(piperidin-2-yl)butanoic acid hydrochloride can be prepared through various routes, including nucleophilic substitution and condensation reactions. One common approach involves the reaction of piperidine derivatives with appropriate alkylating agents or carboxylic acids under controlled conditions. The hydrochloride salt form is often preferred due to its enhanced solubility and stability, which are critical factors in pharmaceutical applications.

The pharmacological properties of 4-(piperidin-2-yl)butanoic acid hydrochloride have been studied in detail, with particular emphasis on its bioavailability, metabolism, and toxicological profile. Recent findings suggest that the compound exhibits favorable pharmacokinetic characteristics, making it suitable for oral administration. Additionally, its metabolic stability has been evaluated in vitro and in vivo, providing valuable insights into its potential as a drug candidate.

One of the most exciting developments involving 4-(piperidin-2-yl)butanoic acid hydrochloride is its role as an intermediate in the synthesis of opioid receptor agonists and antagonists. Researchers have demonstrated that this compound can be effectively transformed into molecules with high affinity for μ-opioid receptors, which are key targets in the treatment of chronic pain conditions. These findings underscore the importance of 4-(piperidin-2-yl)butanoic acid hydrochloride as a building block in medicinal chemistry.

Furthermore, the compound has been utilized in the design of peptide mimetics, which are molecules that mimic the structure and function of natural peptides. By incorporating 4-(piperidin-2-yl)butanoic acid hydrochloride into peptide sequences, researchers have been able to create compounds with enhanced stability and bioactivity. This approach has opened new avenues for the development of peptide-based therapeutics targeting various disease states.

In conclusion, 4-(Piperidin-2-yl)butanoic acid hydrochloride (CAS No. 63987-69-9) is a versatile and valuable compound with significant potential in pharmaceutical research and development. Its unique structure, favorable pharmacological properties, and diverse applications make it an essential tool for scientists working at the forefront of drug discovery.

• 63690-20-0(4-(2-methylpiperidin-1-yl)pentanoic acid hydrochloride (1:1))
• 19615-30-6(2-Piperidylacetic Acid Hydrochloride)
• 19832-04-3(2-Piperidylacetic Acid)
• 4088-33-9(3-(2-piperidyl)propanoic acid)
• 61042-49-7(Heptanoic acid, 7-[(1-methylnonyl)amino]-, hydrochloride)
• 860764-88-1(2-Piperidineaceticacid, 6-methyl-)
• 887587-19-1(2-(2-methylpiperidin-4-yl)acetic acid)
• 64625-19-0(2-(2S)-piperidin-2-ylacetic acid)
• 99310-43-7(3-(2-piperidyl)propanoic acid;hydrochloride)
• 1043392-08-0((2S)-2-Piperidinebutanoic acid)